MAGNOLIA MEDICAL TECHNOLOGIES, INC.
Profile
Company Names
MAGNOLIA MEDICAL TECHNOLOGIES, INC.
Addresses
200 WEST MERCER STREET, SUITE 500, SEATTLE, WA 98119
200 WEST MERCER STREET SUITE 500, SEATTLE, WA 98119
2001 - 6TH AVENUE SUITE 1630, SEATTLE, WA 98121
2001 - 6TH AVENUE SOUTH, SUITE 1630, SEATTLE, WA 98121
821 SECOND AVENUE, SUITE 800, SEATTLE, WA 98104
815 FIRST AVENUE, #140, SEATTLE, WA 98104
Phone Numbers
(888) 617-3420
(206) 673-2500
(206) 418-6720
Entity Type:
CORPORATION
Industry:
OTHER HEALTH CARE, OTHER TECHNOLOGY
Year Incorporated:
2011
State Incorporated:
WASHINGTON
Total Amount Raised:
$94,337,908.00
Number of Funding Rounds:
9
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
9
2022-01-10
$43,380,144.00
$46,380,143.00
$2,999,999.00
Equity
8
2018-12-18
$19,552,560.00
$19,999,998.00
$447,438.00
Equity
7
2016-06-29
$21,007,106.00
$21,007,106.00
$0.00
Equity
6
2016-05-31
$70,000.00
$1,000,000.00
$930,000.00
Debt
5
2016-02-22
$1,365,000.00
$3,000,000.00
$1,635,000.00
Debt
4
2015-05-19
$6,235,322.00
$6,938,380.00
$703,058.00
Equity
3
2013-08-30
$2,512,003.00
$2,512,003.00
$0.00
Equity
2
2012-10-29
$50,000.00
$1,000,000.00
$950,000.00
Debt
1
2011-11-08
$165,773.00
$1,000,000.00
$834,227.00
Debt
People
First Name
Middle Name
Last Name
Titles
Related Companies
JOSH
BALTZELL
DIRECTOR
GARHENG
KONG
DIRECTOR
CEMPRA HOLDINGS, LLC
| APPLIED GENETIC TECHNOLOGIES CORP
| VIAMET PHARMACEUTICALS INC
| ALDAGEN INC
| TRANSENTERIX INC
| CANCERGUIDE DIAGNOSTICS, INC.
| SARCODE BIOSCIENCE INC.
| SOFINNOVA VENTURE PARTNERS VIII, L.P.
| HISTOGENICS CORP
| CEMPRA, INC.
| ALIMERA SCIENCES INC
| FIRST AID BEVERAGES, INC.
| SOFINNOVA HEALTHQUEST PARTNERS, L.P.
| TRICE MEDICAL, INC.
| LONGWOOD OPPORTUNITY OFFSHORE FUND, LTD
| LONGWOOD OFFSHORE, LTD.
| CASTLE BIOSCIENCES INC
| STRONGBRIDGE BIOPHARMA PLC
| ACUTA OPPORTUNITY OFFSHORE FUND, LTD.
| ACUTA CAPITAL OFFSHORE FUND, LTD.
| HEALTHQUEST PARTNERS II, L.P.
| MAGNOLIA MEDICAL TECHNOLOGIES, INC.
| VENUS CONCEPT LTD.
| ALCRESTA THERAPEUTICS, INC.
| MELINTA THERAPEUTICS, INC. /NEW/
| AVEDRO INC
| CLEANSLATE CENTERS, INC.
| BARDY DIAGNOSTICS, INC.
| HEALTHQUEST PARTNERS III, L.P.
| HEALTHQUEST AJAX II SPV, L.P.
| AJAX HEALTH II LLC
| VENUS CONCEPT INC.
| HEALTHQUEST AJAX III SPV, L.P.
| AJAX HEALTH III LLC
| HEALTHQUEST AJAX III-A SPV, L.P.
| HEALTHQUEST MADISON SPV, L.P.
| HEALTHQUEST PARTNERS IV, L.P.
| HEALTHQUEST TACTICAL OPPORTUNITIES FUND, L.P.
| HOME HOSPITAL NEWCO, INC.
| HQTOF ENDEAVOR SPV, L.P.
| HQTOF ENDEAVOR SPV-B, L.P.
| NOMAD HEALTH, INC.
MARC-ANDRE
MARCOTTE
DIRECTOR
PAUL
MEISTER
DIRECTOR
MAGNOLIA MEDICAL TECHNOLOGIES, INC.
| QUANTERIX CORP
| GCM GROSVENOR CALIFORNIA IMPACT SBIC FUND, L.P.
| CIC-FPRT ABSOLUTE RETURN PORTFOLIO, LTD.
| SAN GABRIEL FUND 3, L.P.
| GCM PATRIOT, LLC
| GCM GROSVENOR OPPORTUNISTIC CREDIT FUND V, LTD.
| GCM TRIBE, LLC
| TITANIUM F2 FUND, LTD
| GCM RANGER, LLC
| GROSVENOR OPPORTUNISTIC MULTI-STRATEGY FUND, L.P.
| GROSVENOR INSTITUTIONAL PARTNERS (PF), LTD.
| GCM GROSVENOR SPECIAL OPPORTUNITIES FUND, L.P.
| VTV THERAPEUTICS INC.
| MCG ALTSCAPE FUND, L.P
| KUMANU, INC.
| ACTIV SURGICAL, INC.
| MERCY BIOANALYTICS, INC.
| ARBOR BIOTECHNOLOGIES, INC.
| LUMACYTE, INC.
| NOVALIS LIFESCIENCES INVESTMENTS II, L.P.
| PERFECT AIR HOLDCO LLC
| PANTHER MANAGEMENT HOLDCO LLC
| LEVITASBIO, INC.
| UPKARA INC.
| TELESIS BIO INC.
| AMBIENT BIOSCIENCES, INC.
| BLUEWHALE BIO, INC.
| FLYWHEEL EXCHANGE INC.
| GCM GROSVENOR CREDIT SECONDARIES STRUCTURED NOTE 2025, L.P.
| GCM GROSVENOR CREDIT SECONDARIES STRUCTURED NOTE 2025 FEEDER, L.P.
| EVEREST BIOLABS, INC.
RANDY
SCOTT
EXECUTIVE OFFICER, DIRECTOR
STATION X INC.
| SOFINNOVA HEALTHQUEST PARTNERS, L.P.
| VESTAGEN TECHNICAL TEXTILES, INC.
| HEALTHQUEST PARTNERS II, L.P.
| VESTAGEN PROTECTIVE TECHNOLOGIES, INC.
| AVIZIA, INC.
| SLIPCHIP CORP
| SPRINGBUK, INC.
| MAGNOLIA MEDICAL TECHNOLOGIES, INC.
| TRICE MEDICAL, INC.
| THIRTY MADISON, INC.
| 83BAR, INC.
| SOLABORATE INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

